Article
Arg25Pro (c.915G>C) polymorphism of transforming growth factor β1 gene increases the risk of developing Graves' disease.
International immunopharmacology - 1 Jun 2014
Doğru-Abbasoğlu Semra, Vural Pervin, Baki Merve, Özderya Ayşenur, Karadağ Berrin, Uysal Müjdat
Abstract excerpt
BACKGROUND: Graves' disease (GD) arises due to complex interactions between genetic and environmental factors. Transforming growth factor β1 (TGFβ1) is required to maintain immune homeostasis, and is implicated in lymphocyte infiltration, thyroid follicular cell hyperplasia, and production of autoantibody in the thyroid gland of patients with GD. AIM: The aim of the present study was to investigate the possible...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
